Garcia-Maldonado, Efren
Huber, Andrew D. http://orcid.org/0000-0002-3790-8368
Chai, Sergio C. http://orcid.org/0000-0002-8257-8599
Nithianantham, Stanley http://orcid.org/0000-0001-6238-647X
Li, Yongtao http://orcid.org/0000-0003-0083-2328
Wu, Jing
Poudel, Shyaron
Miller, Darcie J.
Seetharaman, Jayaraman
Chen, Taosheng http://orcid.org/0000-0001-6420-3809
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM118041)
Article History
Received: 19 September 2023
Accepted: 29 April 2024
First Online: 14 May 2024
Competing interests
: Authors Taosheng Chen and Yongtao Li declare the following competing financial interest(s): The authors have the following patents related to compounds in this manuscript: (1) Chen T, Lin W, Wang Y. 1,4,5- Substituted 1,2,3-Triazole Analogs as Antagonists of the Pregnane X Receptor. International Patent Application published as WO/2017/165139, 2017; US Patent Application published as US 2019/0077770 A1, 2019. US patent No. 10,550,091 B2 issued, 2020. (2) Chen T, Li Y, Lin W. Small Molecule Modulators of Human Pregnane X Receptor. US Provisional Application No. 63/333,929. Filing date: April 22, 2022. The remaining authors declare no competing interests.